NCT00434525

Laparoscopic Sleeve Gastrectomy With and Without Omentectomy

Metabolic Effects of Laparoscopic Sleeve Gastrectomy With or Without Omentectomy: Prospective Randomized Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: North Texas Veterans Healthcare System · Federal
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

* The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity. * The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by sleeve gastrectomy and omentectomy (omentum or intra-abdominal fat removal) will provide clinical and metabolic benefits for morbidly obese patients.

Detailed description

This is a phase 3 prospective randomized trial.

Conditions

• Morbid Obesity

Interventions

Type	Name	Description
PROCEDURE	Laparoscopic restrictive procedure	Patients will receive laparoscopic sleeve gastrectomy with or without omentectomy
PROCEDURE	Sleeve gastrectomy	Sleeve gastrectomy

Timeline

• Start date: 2008-01-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2007-02-13
• Last updated: 2009-12-15

Locations

1 site across 1 country: United States